Literature DB >> 1583873

Animal models for lysosomal storage diseases: a new case of feline mucopolysaccharidosis VI.

P Di Natale1, T Annella, A Daniele, G Spagnuolo, R Cerundolo, D de Caprariis, A E Gravino.   

Abstract

Two long-haired Siamese cats are reported with clinical manifestations of human mucopolysaccharidosis VI (Maroteaux-Lamy disease): facial dysmorphia, dysostosis multiplex, paralysis. Urine of the two affected animals contained a high concentration of glycosaminoglycans, as detected by the dimethylmethylene blue test. Qualitative analysis, performed by thin-layer chromatography of the cetylpyridinium chloride-precipitable material, showed dermatan sulphate. Excessive incorporation of [35S]sulphate in the intracellular mucopolysaccharide of cultured fibroblasts and deficiency of arylsulphatase B in such cells indicate that these cats are affected by Maroteaux-Lamy disease. They should thus be considered the first European case of feline mucopolysaccharidosis VI.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1583873     DOI: 10.1007/bf01800339

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  20 in total

1.  Alpha-L-iduronidase deficiency in a cat: a model of mucopolysaccharidosis I.

Authors:  M E Haskins; P F Jezyk; R J Desnick; S K McDonough; D F Patterson
Journal:  Pediatr Res       Date:  1979-11       Impact factor: 3.756

2.  Human N-acetylgalactosamine-4-sulphatase biosynthesis and maturation in normal, Maroteaux-Lamy and multiple-sulphatase-deficient fibroblasts.

Authors:  J A Taylor; G J Gibson; D A Brooks; J J Hopwood
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

3.  Purification and properties of feline and human arylsulfatase B isozymes. Evidence for feline homodimeric and human monomeric structures.

Authors:  M M McGovern; D T Vine; M E Haskins; R J Desnick
Journal:  J Biol Chem       Date:  1982-11-10       Impact factor: 5.157

4.  Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system.

Authors:  R M Shull; N E Hastings; R R Selcer; J B Jones; J R Smith; W C Cullen; G Constantopoulos
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

5.  Morphologic and biochemical studies of canine mucopolysaccharidosis I.

Authors:  R M Shull; R G Helman; E Spellacy; G Constantopoulos; R J Munger; E F Neufeld
Journal:  Am J Pathol       Date:  1984-03       Impact factor: 4.307

6.  Biosynthesis and maturation of arylsulfatase B in normal and mutant cultured human fibroblasts.

Authors:  F Steckel; A Hasilik; K von Figura
Journal:  J Biol Chem       Date:  1983-12-10       Impact factor: 5.157

7.  Mucopolysaccharidosis in a cat with arylsulfatase B deficiency: a model of Maroteaux-Lamy syndrome.

Authors:  P F Jezyk; M E Haskins; D F Patterson; W J Mellman; M Greenstein
Journal:  Science       Date:  1977-11-25       Impact factor: 47.728

8.  Spinal cord compression and hindlimb paresis in cats with mucopolysaccharidosis VI.

Authors:  M E Haskins; S A Bingel; J W Northington; C D Newton; R D Sande; P F Jezyk; D F Patterson
Journal:  J Am Vet Med Assoc       Date:  1983-05-01       Impact factor: 1.936

9.  A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures.

Authors:  R W Farndale; C A Sayers; A J Barrett
Journal:  Connect Tissue Res       Date:  1982       Impact factor: 3.417

10.  The pathology of the feline model of mucopolysaccharidosis VI.

Authors:  M E Haskins; G D Aguirre; P F Jezyk; D F Patterson
Journal:  Am J Pathol       Date:  1980-12       Impact factor: 4.307

View more
  2 in total

1.  Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes.

Authors:  A C Crawley; G Yogalingam; V J Muller; J J Hopwood
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

2.  Mucopolysaccharidosis VI in cats - clarification regarding genetic testing.

Authors:  Leslie A Lyons; Robert A Grahn; Francesca Genova; Michela Beccaglia; John J Hopwood; Maria Longeri
Journal:  BMC Vet Res       Date:  2016-07-02       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.